Patients at Southmead Hospital will now be screened for genetic variants that affect how they respond to the common stroke medication clopidogrel. By identifying resistance early, clinicians can tailor prescriptions to ensure patients receive effective protection against future strokes while reducing the likelihood of hospital readmissions.